UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Integrins in T Cell Physiology

International journal of molecular sciences, 2018-02, Vol.19 (2), p.485

2018

Link zum Volltext

Verfügbarkeit prüfen

Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma

Molecular cancer therapeutics, 2008-08, Vol.7 (8), p.2476-2485

2008

Link zum Volltext

Verfügbarkeit prüfen

Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer

Clinical cancer research, 2011-07, Vol.17 (14), p.4901-4914

2011

Link zum Volltext

Verfügbarkeit prüfen

Involvement of autophagy in ovarian cancer: a working hypothesis

Journal of ovarian research, 2012-09, Vol.5 (1), p.22-22, Article 22

2012

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial

Journal of pain and symptom management, 2016-12, Vol.52 (6), p.783-794.e6

2016

Link zum Volltext

Verfügbarkeit prüfen

Expression and Clinical Significance of the Autophagy Proteins BECLIN 1 and LC3 in Ovarian Cancer

BioMed research international, 2014-01, Vol.2014, p.462658-10

2014

Link zum Volltext

Verfügbarkeit prüfen

PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells

Journal of molecular endocrinology, 2014-10, Vol.53 (2), p.247-258

2014

Link zum Volltext

Verfügbarkeit prüfen

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network

BMC cancer, 2009-11, Vol.9 (1), p.388-388, Article 388

2009

Link zum Volltext

Verfügbarkeit prüfen

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression

International journal of clinical oncology, 2018-04, Vol.23 (2), p.281-286

2018

Link zum Volltext

Verfügbarkeit prüfen

PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration

Genes & cancer, 2014-07, Vol.5 (7-8), p.226-239

2014

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

BMC cancer, 2012-04, Vol.12 (1), p.158-158, Article 158

2012

Link zum Volltext

Verfügbarkeit prüfen

Resveratrol inhibits IL‐6‐induced ovarian cancer cell migration through epigenetic up‐regulation of autophagy

Molecular carcinogenesis, 2017-03, Vol.56 (3), p.1164-1181

2017

Link zum Volltext

Verfügbarkeit prüfen

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

The New England journal of medicine, 2018-04, Vol.378 (15), p.1408-1418

2018

Link zum Volltext

Verfügbarkeit prüfen

Ethics of appropriateness, in oncology and medicine

Clinical management issues, 2007-06, Vol.1 (2), p.43-44

Alabiso, Oscar

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

British journal of cancer, 2019-01, Vol.120 (1), p.57-62

2019

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study of Three-Weekly Docetaxel and Weekly Trastuzumab in HER2-Overexpressing Advanced Breast Cancer

Oncology, 2004-01, Vol.66 (1), p.38-45

2004

Link zum Volltext

Verfügbarkeit prüfen

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Annals of oncology, 2019-05, Vol.30 (5), p.766-773

2019

Link zum Volltext

Verfügbarkeit prüfen

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

The lancet oncology, 2019-06, Vol.20 (6), p.862-876

2019

Link zum Volltext

Verfügbarkeit prüfen

Venous thromboembolism in non-small cell lung cancer patients: retrospective analysis of cases treated at the Oncology Day Hospital of Novara, Italy

Italian journal of medicine, 2013-01, Vol.7 (2), p.113-117

2013

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

The lancet oncology, 2018-04, Vol.19 (4), p.474-485

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Treatment for Elderly Patients with Colon Cancer. An Observational Study

Anticancer research, 2008-07, Vol.28 (4C), p.2513-2518

2008

Link zum Volltext

Verfügbarkeit prüfen

Autophagy and thyroid carcinogenesis: genetic and epigenetic links

Endocrine-related cancer, 2014-02, Vol.21 (1), p.R13-R29

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(68)
Berichte
(1)

Sprache

Englisch
(69)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Humans
(49)
Oncology
(40)
Female
(39)
Aged
(35)
Middle Aged
(34)
Male
(31)
Adult
(23)
Aged, 80 And Over
(16)
Chemotherapy
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Biological And Medical Sciences
(14)
Medical Sciences
(14)
Tumors
(14)
Cancer Research
(11)
Neoplasm Staging
(11)
Treatment Outcome
(10)
Disease-Free Survival
(8)
Italy
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Integrins in T Cell Physiology

Autophagy inhibition enhances anthocyanin-induced apoptosis in hepatocellular carcinoma

Increased Detection Sensitivity for KRAS Mutations Enhances the Prediction of Anti-EGFR Monoclonal Antibody Resistance in Metastatic Colorectal Cancer

Involvement of autophagy in ovarian cancer: a working hypothesis

Comparison of the Tolerability Profile of Controlled-Release Oral Morphine and Oxycodone for Cancer Pain Treatment. An Open-Label Randomized Controlled Trial

Expression and Clinical Significance of the Autophagy Proteins BECLIN 1 and LC3 in Ovarian Cancer

PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells

Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte oncology network

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression

PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration

Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study

Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI study

Resveratrol inhibits IL‐6‐induced ovarian cancer cell migration through epigenetic up‐regulation of autophagy

Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer

Ethics of appropriateness, in oncology and medicine

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

A Phase II Study of Three-Weekly Docetaxel and Weekly Trastuzumab in HER2-Overexpressing Advanced Breast Cancer

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Venous thromboembolism in non-small cell lung cancer patients: retrospective analysis of cases treated at the Oncology Day Hospital of Novara, Italy

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

Adjuvant Treatment for Elderly Patients with Colon Cancer. An Observational Study

Autophagy and thyroid carcinogenesis: genetic and epigenetic links

Suchergebnisse filtern